Valeant Pharmaceuticals

Quality Associate II, Product Release & Receiving Inspection

US-NY-Rochester
Job ID
9320
Category
Operations
Pos. Type
Full Time

Overview

The Quality Associate II ensures product compliance through the inspection of incoming materials and final product.

 

Work Schedule:  A or B shift - 6:00 am - 6:00 pm - 12hrs day 

Responsibilities

  • Inspect and measure incoming materials and components using calibrated measuring instruments.
  • Notify chemistry for receipts that require lab analysis.
  • Disposition incoming products and label containers to reflect the inspection and test results in accordance with procedures.
  • Document inspection results and maintain filing system.
  • Review sterilization records/documentation and approve the release of autoclave cycles.
  • Interpret procedures and specifications to release acceptable product.
  • Review final product quality records and verify counts for evidence of compliance to the quality system transactions to release accepted incoming materials, components and outgoing products.
  • Place and remove lots on hold through interaction with purchasing, manufacturing and quality.
  • Maintain records in accordance with the Record Retention Policies.  

 

A Shift - 12 hour Shift including every other weekend and overtime.

 

 

 

Qualifications

  • High School diploma or equivalent is required.
  • Must be able to read, write and speak English and possess basic math skills.
  • Demonstrated ability to work in a team environment.
  • Excellent interpersonal skills.
  • Ability to meet physical requirements (medical clearance is required)
  • Shift flexibility and ability to work overtime is required.

EXPERIENCE

3+ years’ experience in a GMP environment preferred.  Knowledge of Excel, Word.

 

TSA background check and certified cargo screener training required within 30 days.

 

 

 

 

Be Aware of Recruiting Fraud

#KBL

Options

Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
Share on your newsfeed